News

The medication is a generic version of Wyeth’s Tazocin, an injectable antibiotic. Hospira will offer piperacillin/tazobactam as a powder for solution for injection or infusion in 2.25g and

The Phase II, double-blind, vehicle-controlled study will determine the efficacy, safety and tolerability of SRD441 in patients with atopic dermatitis (AD). Results from the Phase II study for

According to the company, the Capsule Neuron platform is a touch-enabled bedside device that can communicate wirelessly and features display of connectivity status at the point of care.

The decreased loss was primarily attributable to a $7.4 million decrease in R&D costs, the recognition in the 2008 period of the $5.94 million non-refundable license fee received

Revenue for the fiscal third quarter of 2009 was $75.31 million, an increase of 12%, compared to $67.03 million for the prior-year period. For the first nine months

According to Mayer Laboratories, the Today Sponge affords the freedom and flexibility of 24-hour contraceptive protection, and offers a safe and effective non-hormonal birth control alternative for women.

The company has appointed Ugo DeBlasi as its new CFO. In this position, Mr DeBlasi will provide leadership to the Celera finance, investor relations and information technology function,

On March 30, 2009, the FDA granted approval for a generic version of AstraZeneca’s Pulmicort Respules (budesonide inhalation suspension) to Apotex. The lawsuit follows Apotex’s indication of intent

Mr Sweeney has been founder and CEO of eight healthcare service companies including Bridge Medical, a provider of bedside barcode scanning for medication administration, and CardioNet, a developer